Table 1 Patient demographics and baseline characteristics
Characteristic | All patients (n = 64) |
|---|---|
Median age, years (range) | 52.5 (28.0–70.0) |
Sex | |
Male | 53 (82.8) |
Female | 11 (17.2) |
Race, Asian | 64 (100.0) |
Region, mainland China | 64 (100.0) |
BCLC staging at study entry | |
B | 17 (26.6) |
C | 47 (73.4) |
ECOG performance score | |
0 | 40 (62.5) |
1 | 24 (37.5) |
Child–Pugh score | |
5 | 58 (90.6) |
6 | 6 (9.4) |
Extrahepatic spread | 37 (57.8) |
Macrovascular invasion | 7 (10.9) |
AFP level | |
≥ 400 ng/mL | 26 (40.6) |
< 400 ng/mL | 38 (59.4) |
HCC etiology, HBV | |
Yes | 58 (90.6) |
No | 6 (9.4) |
Prior liver local regional therapy | 47 (73.4) |
Radio frequency ablation | 11 (17.2) |
Microwave frequency ablation | 4 (6.3) |
TACE or TE | 31 (48.4) |
Hepatic artery infusion chemotherapy | 14 (21.9) |
Other (including surgery) | 5 (7.8) |